Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Optimizing Disease Management to Improve Alopecia Areata Quality of CareRelease Date:Quality Improvement Inflammation & Immunology China Driving Timely Biomarker Testing to Optimize Treatment Decisions for Colorectal Cancer Patients Across CanadaRelease Date:Partner: Colorectal Cancer Canada (CCC)Quality Improvement, Research Oncology Canada Providing Appropriate Medical Care for IBD PatientsRelease Date:Partner: Japanese Society for Inflammatory Bowel Disease (JSIBD)Quality Improvement Inflammation & Immunology Japan Fostering Educational Initiatives for ALK+ Metastatic Non-Small Cell Lung Cancer(mNSCLC) Tyrosine Kinase Inhibitors(TKI) TherapyRelease Date:Education Oncology Canada Advances in Migraine ManagementRelease Date:Education Internal Medicine USA Optimizing Atopic Dermatitis Quality of Care and Best Practice at Local LevelRelease Date:Quality Improvement Inflammation & Immunology China Addressing HCP Knowledge Gaps in Baseline Assessments for Adults with Ulcerative Colitis Starting S1P Receptor Modulator TherapyRelease Date:Education Inflammation & Immunology USA Use of AI to Improve Speed/Precision of Treatment Selection & Clinical Management for Patients w/ Invasive Mold InfectionsRelease Date:Education Hospital Australia, China, France, Germany, Italy, Korea, Spain, Taiwan, United Kingdom Quality improvement strategies to enhance quality of life in ALK-positive lung cancer patientsRelease Date:Quality Improvement Oncology Spain Efforts to Improve Quality of Migraine CareRelease Date:Partner: The Japanese Headache SocietyQuality Improvement Internal Medicine Japan Title Grant Type Focus Area Country Application Due Date Multidisciplinary Team Education in Duchenne Muscular Dystrophy (see RFP for specific geographic scope)Release Date:Education Rare Disease All 2023/2024 Global NASH ASPIRERelease Date:Research Internal Medicine All Improving Metastatic Breast Cancer (mBC) Quality of Care and Equity via Meaningful Capacity Building in South East AsiaRelease Date:Partner: Conquer Cancer®, the ASCO FoundationQuality Improvement Oncology Hong Kong, Indonesia, Malaysia, Myanmar, Papua New Guinea, Philippines, Singapore, Solomon Islands, Taiwan, Thailand, Vietnam Alopecia Areata Education for Pediatric Dermatologists, Dermatologists, and Advanced Practice ProvidersRelease Date:Education Inflammation & Immunology USA Implementation of Revised USP <797> Pharmaceutical Compounding-Sterile Preparations: Challenges and OpportunitiesRelease Date:Education Hospital USA Improving Care for Patients with Multiple MyelomaRelease Date:Education Oncology USA HRRm Testing in Metastatic Prostate CancerRelease Date:Education Oncology All Advancing Oncology Education for Healthcare ProfessionalsRelease Date:Education Oncology Benin, Burkina Faso, Burundi, Cameroon, Central African Republic, Chad, Comoros, Congo, Congo, The Democratic Republic, Cote D'ivoire, Djibouti, Gabon, Guinea, Madagascar, Mali, Niger, Rwanda, Senegal, Seychelles, Togo Providing Appropriate Medical Care for IBD PatientsRelease Date:Partner: Japanese Society for Inflammatory Bowel Disease (JSIBD)Quality Improvement Inflammation & Immunology Japan Real World Evidence of Abrocitinib in Patients with Moderate-to-Severe Atopic DermatitisRelease Date:Research Inflammation & Immunology All Addressing Gaps in Care for Patients with Multiple Myeloma (Europe)Release Date:Education Oncology All Improving Breast Cancer (BC) Quality of Care via Meaningful Capacity Building in Sub-Saharan AfricaRelease Date:Partner: Conquer Cancer®, the ASCO FoundationReview Process: Expert Review PanelQuality Improvement Oncology Congo, The Democratic Republic, Ethiopia, Ghana, Malawi, Mali, Mozambique, Rwanda, Senegal, Tanzania, United Republic of, Uganda, Zambia, Zimbabwe